Search research articles
Contact Us
Filters
Showing results (661-670 of 663) with videos related to
Page
of 67
Sort By:
You have reached the last page of results.
This site can display upto 663 results.
BMC Cancer
|
October 14, 2023
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial
Zhongjun Xia, Yun Leng, Baijun Fang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 28, 2025
Chinese expert consensus on hematologic malignancy karyotyping
Zailin Yang, Shuang Chen, Mingyu Zhao, et al.
American Journal of Hematology
|
May 2, 2023
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase
Sen Yang, Xiaoshuai Zhang, Robert Peter Gale, et al.
Page
of 67
Search research articles
Search
Showing results (661-670 of 663) with videos related to
Sort By:
Page
of 67
You have reached the last page of results.
This site can display upto 663 results.
BMC Cancer
|
October 14, 2023
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial
Zhongjun Xia, Yun Leng, Baijun Fang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 28, 2025
Chinese expert consensus on hematologic malignancy karyotyping
Zailin Yang, Shuang Chen, Mingyu Zhao, et al.
American Journal of Hematology
|
May 2, 2023
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase
Sen Yang, Xiaoshuai Zhang, Robert Peter Gale, et al.
Page
of 67